Loss of the Y chromosome in male patients with Myeloid Neoplasms by Ambrósio, A. et al.
21.ª Reunião Anual 
Sociedade Portuguesa Genética Humana 
81 
 
P5 | Cancer Genetics 
Loss of the Y chromosome in male patients with Myeloid Neoplasms 
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Loss of the Y chromosome (L0Y) is describe as a both a normal age - related event and a 
marker of a neoplastic clone in haematological diseases. In order to understand the relationship 
between L0Y chromosome and the different myeloid neoplasms, we retrospectively analysed 
cytogenetic results of 891 males' patients, from 1995 to 2016 with myeloid neoplasms. Sixty one 
patients showed L0Y. Of the 61 patients without Y chromosome 24 (2,7%) had Myelodysplastic 
Syndromes (MDS); 24 (2,7%) had Myeloproliferative Neoplasms (MN); 6 (0,67%) had Neoplasm 
Myelodysplastic Syndrome / Myeloproliferative Neoplasms (MDS/MN) and 7 (0,79%) had Acute 
Myeloid Leukaemia (AML). These percentages can be different if we consider only the pathology 
in which was found the L0Y: 7,7% of all patients with MDS (310); 6,1% of all patients with NM 
(391); 6,6% in the patients with MDS/MN (90) and 7,6% in patients with AML (92). There are 
few reports of L0Y associated with Myeloid Neoplasms, since this has been considered mainly 
an age-related event. There for the tendency of L0Y in our data, seems to indicate that careful 
consideration should be taken when evaluating male patients with L0Y. 
